Increase in the prevalence of various types of cancers, increase in aging population and biomarker identification systems and changed lifestyles, as well as technological advancements in molecular diagnostic techniques accelerate the growth of the oncology molecular diagnostics market. In addition, increased demand for rapid and accurate diagnostics coupled with advancements in next-generation sequencing (NGS) techniques …